For the pharmaceuticals industry, whilst the impact of the Covid19 crisis has yet to be seen, already questions are being asked about whether it makes sense to have outsourced manufacturing of medicines, as supply chains come under threat through …
With the UK now about to leave the EU, the pressure on procurement and supply chains is likely to intensify shortly, as businesses re-organise to the new paradigm.
Also factor that in a recent survey of Chief Procurement Officers by Deloitte, 51% of leaders believe their current teams do not have sufficient skills and capabilities to deliver on their procurement strategy.
Within large pharmaceuticals companies, hiring for procurement professionals has actually been falling. What has been driving this change?
